Why nutrition in early life matters?
Task Force Information
Objectives
The Task Force aims at providing scientific evidence to support guidelines for maternal and infant nutrition to ensure life-time optimal health. It also identifies risk factors for obesity and other health consequences at the earliest stages of life.
Task Force Members
Dr Carolien van Loo-Bouwman – Chair | Yili Innovation Center Europe | Open Innovation Manager | NL |
Dr Euridice Castaneda Gutierrez – Vice-Chair | H&H | Science and Communication Manager | CH |
Prof. Susan Ozanne – Co-Chair | University of Cambridge | Professor | UK |
Dr Marieke Abrahamse-Berkeveld | Danone Nutricia Research | Senior Team Leader Growth & Development | NL |
Prof. Stewart Forsyth* | Independent | Consultant | UK |
Dr Patricia Iozzo* | Italian National Research Council | Researcher | IT |
Dr Renaud Mestdagh | Cargill | Senior Scientist Infant Nutrition | BE |
Dr Elena Oliveros | Abbott Nutrition | Senior Scientist | ES |
Dr Linette Pellis | Ausnutria | Research Scientist | NL |
Dr Keng Ngee Teoh | Ajinomoto | Manager, Quality Assurance and Regulatory Science | FR |
Dr Janna van Diepen | Reckitt Benckiser/Mead Johnson Nutrition | Senior Scientist | NL |
Ms Ching-Yu Chang | ILSI Europe | Scientific Project Manager | BE |
Contact Information
For more detailed information, please contact Ching-Yu Chang at cchang@ilsieurope.be
Activity Overview
Review and Gap Analysis of Factors Affecting Body Composition in Fetal Life, Infancy and Childhood and Association to Long-Term Health - Ongoing -
Objectives
This activity will review the available evidence on the factors that influence body composition during fatal life, infancy and childhood and on the association of body composition with long-term health outcomes. In addition, a gap analysis will be performed to outline future research needs.
Scientific review on biomarkers in early life (prenatal - infancy) to predict childhood obesity risk and metabolic health - Ongoing -
Objectives
The aim of the activity is to review biomarkers in early life that could be used to predict development of childhood obesity and metabolic health. This prediction may drive development and knowledge of personalized (infant) nutrition. The focus of the activity will be on both invasive and non-invasive, perinatal and postnatal biomarkers.
Lipid quality in early life nutrition - Upcoming -
Objectives
The activity aims to generate an overview of the dietary lipid quality in the first year of life and to what extent this brings or relates to health benefits to its consumers with a particular focus on exploring appropriate intake levels of SFA and MUFA.
Expected results
Peer-reviewed journal article (‘white paper’).
The content will cover expert insights and hopefully a concluding consensus on the FA profile of first year of life diet. It will identify knowledge gaps and outline plans for future research and possibly a basis for new EFSA recommendations.
Expert Groups
Review and Gap Analysis of Factors Affecting Body Composition in Fetal Life, Infancy and Childhood and Association to Long-Term Health
Background and Objectives
The clinical significance of differences in body composition (fat, bone and muscle) during fatal life, infancy and childhood on long-term health is currently not known. This activity aims to: review current evidence on the impact of life factors on body composition during infancy and childhood; test for association between body composition at infancy and childhood and long term health outcomes; Perform a gap analysis outlining areas where evidence needs to be generated
Output
These data will be compiled in a peer-reviewed publication with the purpose of informing scientists, policy makers and other stakeholders on knowledge gaps and research directions. Further, the outcomes will provide insight on critical periods of life where body composition measurement should be included to identify at-risk populations.
Expert Group Members
Prof. Neena Modi – Chair | Imperial College London | Professor of Neonatal Medicine | UK |
Dr Euridice Castaneda Gutierrez – Vice-Chair | H&H | Science and Communication Manager | CH |
Dr Marieke Abrahamse-Berkeveld | Danone Nutricia Research | Senior Team Leader Growth & Development | NL |
Dr Federica Amati | Imperial College London | Research Assistant | UK |
Dr Elena Oliveros | Abbott Nutrition | Senior Scientist | ES |
Prof. Susan Ozanne | University of Cambridge | Professor | UK |
Prof. Michael Symonds | University of Nottingham | Head of The Academic Division Child Health | UK |
Dr Carolien van Loo-Bouwmman | Yili Innovation Center Europe | Open Innovation Manager | NL |
Ms Ching-Yu Chang | ILSI Europe | Scientific Project Manager | BE |
Scientific review on biomarkers in early life (prenatal - infancy) to predict childhood obesity risk and metabolic health
Background and Objectives
The aim of the activity is to review biomarkers in early life that could be used to predict development of childhood obesity and metabolic health. The activity will focus on invasive and non-invasive, perinatal and postnatal biomarkers. This activity aims to:
-
Summarise the current evidence for early life (perinatal and postnatal) biomarkers that are able to predict childhood obesity and related metabolic health.
-
Emphasise relevance of combining conventional predictive markers (e.g. early weight gain) with novel applications of metabolomics, epigenetics and microbiota profiling. It will help to more accurately and effectively identify infants at risk to develop obesity.
-
Emphasise importance of validity and reliability of identified biomarkers for application of such biomarkers in (daily) practice.
Output
The highlighted (recent) findings in the development of biomarkers for early life prediction of metabolic health could be used to guide risk prediction and stratification. This prediction may drive development and knowledge of personalised (infant) nutrition to reduce the risk of childhood obesity. Researchers should become aware of the urgency to develop and validate new predictive biomarkers that are both easily detectable and responsive to nutritional interventions.
Expert Group Members
Prof. Romy Gaillard – Chair | Erasmus University Rotterdam | Professor | NL |
Dr Janna van Diepen – Vice Chair | Reckitt Benckiser/Mead Johnson Nutrition | Senior Scientist | NL |
Dr Marieke Abrahamse-Berkeveld | Danone Nutricia Research | Senior Team Leader Growth & Development | NL |
Dr Sophia Blaauwendraad | Erasmus University Rotterdam | Researcher | NL |
Mr Marco Brandimonte-Hernández | University of Granada | ES | |
Dr Maria Carmen Collado | Institute of Agrochemistry and Food Technology | Professor | ES |
Mr Eduard Flores | Institute of Agrochemistry and Food Technology | ES | |
Prof. Angel Gil | University of Granada | Professor | ES |
Dr Patricia Iozzo | Italian National Research Council | Researcher | IT |
Ms Arwen Kamphuis | Erasmus University Rotterdam | NL | |
Dr Karen Knipping | Ausnutria | Senior Research Scientist | NL |
Dr Francisco Javier Ruiz-Ojeda | University of Granada | RG Adipocytes and Metabolism group collaborator | ES |
Dr Carolien van Loo-Bouwman | Yili Innovation Center Europe | Open Innovation Manager | NL |
Ms Ching-Yu Chang | ILSI Europe | Scientific Project Manager | BE |
Carbohydrates in Toddlers’ Nutrition
Joint activity in collaboration with Dietary Carbohydrates Task Force
Background and Objectives
The aim of this work is to compile and systematically review the current evidence from primarily intervention studies as well as observational studies and further suitable information on physiological and health outcomes of digestible and non-digestible carbohydrates consumption for toddlers (1-3 years meaning from 12 till 47 months). With this activity, the task force expects to identify the gaps in research on knowledge of digestible carbohydrates and NDCs in relation to safety, physiological outcomes, and health benefits and to provide recommendations to the scientific community about how to fill these gaps.
Output
The resulting scientific publications and webinars will aim at assessing and providing with evidence to the global scientific community.
Expert Group Members
Dr Bartlomiej Zalewski – Chair | Medical University of Warsaw | PL | |
Dr Renaud Mestdagh – Vice-Chair | Cargill | Senior Scientist Infant Nutrition | BE |
Prof. Christina Campoy | University of Granada | Professor of Paediatrics and DynaHEALTH Lead Investigator | ES |
Prof. Tamas Decsi | University of Pécs | Professor of Paediatrics | HU |
Ms Elisabetta Di Profio | University of Milan | Student | IT |
Dr Maryam Rakhshandehroo | Danone Nutricia Research | Senior Scientist, Growth & Metabolism | NL |
Prof. Hania Szajewska | Medical University of Warsaw | Professor | PL |
Dr Stephan Theis | Südzucker Group | Head of Nutrition Science | DE |
Dr Elaine Vaughan | Sensus | Scientific & Regulatory Affairs | NL |
Prof. Elvira Verduci | University of Milan | Assistant Professor | IT |
Dr Adrienne Weiss | Yili Innovation Center Europe | Open Innovation Project Leader | NL |
Ms Ching-Yu Chang | ILSI Europe | Scientific Project Manager | BE |
Publications
All Publications
Health relevance of lowering postprandial glycaemia in the paediatric population through diet’: results from a multistakeholder workshop
European Journal of Nutrition , 2022
A systematic review of breast milk microbiota composition and the evidence for transfer to and colonisation of the infant gut
Beneficial Microbes, 2022
he intestinal microbiota plays a major role in infant health and development. However, the role of the breastmilk microbiota in infant gut colonisation remains unclear. A systematic review was performed to evaluate the composition of the breastmilk microbiota and evidence for transfer to/colonisation of the infant gut
The microbiota–gut–brain axis: pathways to better brain health. Perspectives on what we know, what we need to investigate and how to put knowledge into practice
Cellular and Molecular Life Sciences, 2022
(2022) 79:80. Commissioned by the Early Nutrition and Long-Term Health, Nutrition and Brain Health, Nutrition, Immunity and Inflammation, Prebiotics and Probiotics Task Forces.
Is there Evidence for Bacterial Transfer via the Placenta and any Role in the Colonization of the Infant Gut? – a Systematic Review
2020
Critical Reviews in Microbiology 2020. Commissioned by the Early Nutrition and Long-Term Health Task Force.
A Systematic Review of the Effects of Increasing Arachidonic Acid Intake on PUFA Status, Metabolism and Health-Related Outcomes in Humans
2019
British Journal of Nutrition 2019. Commissioned by the Early Nutrition and Long Term Health and Nutrient Intake Optimisation Task Forces.
Multimedia
Introductory video
Workshops
‘Health Relevance of Lowering Postprandial Glycaemia in Children and Adolescents through Diet’ ---> Watch the recordings
Completed Expert Groups
Overview of completed activities since 2021
-
Joint nutrition cluster activity on ‘mechanistic insights into the gut-brain axis' in collaboration with Health Benefit Assessment of Foods; Nutrition, Immunity & Inflammation; Nutrition & Brain Health; Prebiotics and Probiotics Task Forces
-
Gestational Diabetes and Diet
-
Early Bacterial Colonization and Potential Implications Later in Life
-
n-3 and n-6 PUFA Intakes, Ratios and Health Effects
-
Early Growth Velocity and Risk of Metabolic Disorders Later in Life